Affinity Asset Advisors’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,746	Closed	-$4.76M	–	101
2024 Q1	$4.76M	Buy	26,746 +1,746	+7%	+$311K	0.59%	42
2023 Q4	$3.1M	Sell	25,000 -32,500	-57%	-$4.03M	0.57%	40
2023 Q3	$6.67M	Buy	+57,500	New	+$6.67M	1.88%	15